GlassScriptPhysician profile
Ariela Noy
NPI 1154392140
$35,963.98
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,210 · 2020: $1,635 · 2021: $13K · 2022: $10K · 2023: $2,151 · 2024: $3,714 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,455 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,160 · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,455.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,160.00 |
| Food and Beverage | $387.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Global Services, LLC | $8,510.00 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $6,507.50 | 2022-2023 | |
| Eusa Pharma (US) LLC | $5,116.25 | 2019 | |
| Adc Therapeutics America, INC. | $3,883.87 | 2022-2024 | |
| Gilead Sciences, INC. | $3,170.00 | 2022 | |
| Pfizer INC. | $2,160.00 | 2024 | |
| Beigene USA, INC. | $2,045.50 | 2021-2023 | Brukinsa |
| Tg Therapeutics, INC. | $1,856.25 | 2021 | |
| Epizyme, INC. | $1,812.50 | 2021 | |
| Sentynl Therapeutics, INC. | $475.00 | 2020 | |
| Kite Pharma, INC. | $164.51 | 2019-2025 | Yescarta |
| Genentech USA, INC. | $118.02 | 2025 | Polivy |
| Pharmacyclics LLC, An Abbvie Company | $74.01 | 2019 | |
| Ge Healthcare | $70.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariela Noy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.